Health-related quality of life questionnaires used in primary biliary cholangitis: a systematic review

References

• Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386(10003):1565–1575.
   PubMed Web of Science ®Google Scholar
• de Liso F, Matinato C, Ronchi M, et al. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature. Clin Chem Lab Med. 2017;56(1):25–31.
   PubMed Web of Science ®Google Scholar
• Dyson JK, Hirschfield GM, Adams DH, et al. Novel therapeutic targets in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol. 2015;12(3):147–158.
   PubMed Web of Science ®Google Scholar
• Mattner J. Impact of microbes on the pathogenesis of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). Int J Mol Sci. 2016;17(11):1864.
   Web of Science ®Google Scholar
• Zhang Y, Li S, He L, et al. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a Meta-analysis. Drug Des Devel Ther. 2015;9:2757–2766.
   PubMed Web of Science ®Google Scholar
• Study protocol for the world health organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res. 1993;2(2):153–159.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622–629.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and Meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–34.
   PubMed Web of Science ®Google Scholar
• Sumskiene J, Kupcinskas L, Sumskas L. Health-related quality of life measurement in chronic liver disease patients. Medicina. 2015;51(4):201–208.
   PubMedGoogle Scholar
• Hawker S, Payne S, Kerr C, et al. Appraising the evidence: reviewing disparate data systematically. Qual Health Res. 2002;12(9):1284–1299.
   PubMed Web of Science ®Google Scholar
• Cerri G, Cocchi CA, Montagna M, et al. Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability. Clin Neurophysiol. 2010;121(8):1321–1328.
   PubMed Web of Science ®Google Scholar
• Montali L, Tanaka A, Riva P, et al. A short version of a HRQoL questionnaire for italian and japanese patients with primary biliary cirrhosis. Dig Liver Dis. 2010;42(10):718–723.
   PubMedGoogle Scholar
• Zec S, Popovic D, Matovic V, et al. Translation and validation of the serbian primary biliary cholangitis-40 questionnaire. PLoS One. 2017;12(4):e0175697.
   PubMed Web of Science ®Google Scholar
• Mells GF, Pells G, Newton JL, et al. UK-PBC Consortium. Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology. 2013;58(1):273–283.
   PubMed Web of Science ®Google Scholar
• Alrubaiy L, Mells G, Flack S, et al. on behalf of the UK-PBC Research Consortium. PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis. Aliment Pharmacol Ther. 2019;50(11-12):1223–1231.
   PubMed Web of Science ®Google Scholar
• Kim WR, Lindor KD, Malinchoc M, et al. Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. Hepatology. 2000;32(5):924–929.
   PubMed Web of Science ®Google Scholar
• Jacoby A, Rannard A, Buck D, et al. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut. 2005;54(11):1622–1629.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45(2):295–300.
   PubMed Web of Science ®Google Scholar
• Rucci P, Taliani G, Cirrincione L, et al. Validity and reliability of the italian version of the chronic liver disease questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis. 2005;37(11):850–860.
   PubMedGoogle Scholar
• van der Plas SM, Hansen BE, de Boer JB, et al. The liver disease symptom index 2.0; validation of a disease-specific questionnaire. Qual Life Res. 2004;13(8):1469–1481.
   PubMed Web of Science ®Google Scholar
• Ware J, Snoww K, Kosinski MA, et al. SF-36 Health survey: manual and interpretation guide. Boston (MA): Nimrod Press; 1993.
   Google Scholar
• Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233.
   PubMed Web of Science ®Google Scholar
• Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33(5):328–336.
   PubMed Web of Science ®Google Scholar
• Belle SH, Porayko MK, Hoofnagle JH, et al. Changes in quality of life after liver transplantation among adults. National institute of diabetes and digestive and kidney diseases (NIDDK) Liver transplantation database (LTD). Liver Transpl. 1997;3(2):93–104.
   Google Scholar
• Torrance GW, Feeny DH, Furlong WJ, et al. Multiattribute utility function for a comprehensive health status classification system. Health utilities index mark 2. Med Care. 1996;34(7):702–722.
   PubMed Web of Science ®Google Scholar
• Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–128.
   PubMed Web of Science ®Google Scholar
• Hunt SM, Mckenna SP, Mcewen J, et al. The nottingham health profile: subjective health status and medical consultations. Soc Sci Med A. 1981;15(3 Pt 1):221–229.
   PubMedGoogle Scholar
• Reeve BB, Hays RD, Bjorner JB, et al. PROMIS Cooperative Group. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported outcomes measurement information system (PROMIS). Med Care. 2007;45(5 Suppl 1):S22–S31.
   PubMed Web of Science ®Google Scholar
• Yagi M, Tanaka A, Namisaki T, et al. Japan PBC Study Group (JPBCSG). Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study. J Gastroenterol. 2018;53(10):1151–1158.
   PubMed Web of Science ®Google Scholar
• Turco M, Cazzagon N, Franceschet I, et al. Morning bright light treatment for Sleep-Wake disturbances in primary biliary cholangitis: a pilot study. Front Physiol. 2018;9:1530.
   PubMed Web of Science ®Google Scholar
• Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, et al. Assessment of health related quality of life in polish patients with primary biliary cirrhosis. Clin Res Hepatol Gastroenterol. 2016;40(4):471–479.
   PubMed Web of Science ®Google Scholar
• Bondini S, Kallman J, Dan A, et al. Health-related quality of life in patients with chronic hepatitis B. Liver Int. 2007;27(8):1119–1125.
   PubMed Web of Science ®Google Scholar
• Charatcharoenwitthaya P, Talwalkar JA, Angulo P, et al. Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. Dig Dis Sci. 2010;55(2):476–483.
   PubMed Web of Science ®Google Scholar